Tuberculous Prostatic Abscess with Prostatorectal Fistula after Intravesical Bacillus Calmette-Guérin Immunotherapy

Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is a common treatment modality for bladder cancer after transurethral resection of a bladder tumor. This therapy is generally safe, and development of a prostatic abscess with a prostatorectal fistula after intravesical BCG immunotherapy is a...

Full description

Bibliographic Details
Published in:Clinical Endoscopy
Main Authors: Jeong Ho Eom, Jai Hoon Yoon, Seok Won Lee, Hyo Sun Kim, Tae Young Park, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim
Format: Article
Language:English
Published: Korean Society of Gastrointestinal Endoscopy 2016-09-01
Subjects:
Prostate
Abscess
Fistula
Tuberculosis
Online Access:http://www.e-ce.org/upload/pdf/ce-2015-145.pdf
Description
Summary:Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is a common treatment modality for bladder cancer after transurethral resection of a bladder tumor. This therapy is generally safe, and development of a prostatic abscess with a prostatorectal fistula after intravesical BCG immunotherapy is a very rare complication. This finding was incidentally obtained by the authors, who examined a patient with colonoscopy for evaluation of abdominal pain. The patient was successfully treated with antitubercular drugs. To the authors’ knowledge, this is the first report of a patient with a tuberculous prostatic abscess with prostatorectal fistula after BCG immunotherapy in South Korea.
ISSN:2234-2400
2234-2443

Similar Items